BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 17699851)

  • 21. SFRP1 Promoter Methylation and Renal Carcinoma Risk: A Systematic Review and Meta-Analysis.
    Mo S; Su Z; Heng B; Chen W; Shi L; Du X; Lai C
    J Nippon Med Sch; 2018; 85(2):78-86. PubMed ID: 29731501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
    Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
    Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secreted frizzled related protein 1 regulates Wnt signaling for BMP2 induced chondrocyte differentiation.
    Gaur T; Rich L; Lengner CJ; Hussain S; Trevant B; Ayers D; Stein JL; Bodine PV; Komm BS; Stein GS; Lian JB
    J Cell Physiol; 2006 Jul; 208(1):87-96. PubMed ID: 16575902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M; Delahunt B; Störkel S; Grebem SK
    Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
    Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
    Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
    Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
    Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
    Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Ueno K; Yamamura S; Zaman MS; Khatri G; Chen Y; Saini S; Majid S; Deng G; Ishii N; Dahiya R
    Int J Cancer; 2011 Apr; 128(8):1793-803. PubMed ID: 20549706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma.
    Deville JL; Bartoli C; Berenguer C; Fernandez-Sauze S; Kaafarani I; Delfino C; Fina F; Salas S; Muracciole X; Mancini J; Lechevallier E; Martin PM; Figarella-Branger D; Ouafik L; Daniel L
    Int J Cancer; 2009 Nov; 125(10):2307-15. PubMed ID: 19610056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgG is involved in the migration and invasion of clear cell renal cell carcinoma.
    Sheng Z; Liu Y; Qin C; Liu Z; Yuan Y; Hu F; Du Y; Yin H; Qiu X; Xu T
    J Clin Pathol; 2016 Jun; 69(6):497-504. PubMed ID: 26519488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression pattern of Von Hippel-Lindau tumor suppressor protein, MET proto-oncogene, and TFE3 transcription factor oncoprotein in renal cell carcinoma in Upper Egypt.
    Nagi FM; Omar AA; Mostafa MG; Mohammed EA; Abd-Elwahed Hussein MR
    Ultrastruct Pathol; 2011 Apr; 35(2):79-86. PubMed ID: 21299348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytohistopathologic hybrid renal cell carcinoma with papillary and clear cell features.
    Mai KT; Kohler DM; Roustan Delatour NL; Veinot JP
    Pathol Res Pract; 2006; 202(12):863-8. PubMed ID: 17034957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
    Velickovic M; Delahunt B; McIver B; Grebe SK
    Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma.
    Chim CS; Pang R; Fung TK; Choi CL; Liang R
    Leukemia; 2007 Dec; 21(12):2527-36. PubMed ID: 17882284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma.
    Struckmann K; Schraml P; Simon R; Elmenhorst K; Mirlacher M; Kononen J; Moch H
    Cancer Res; 2004 Mar; 64(5):1632-8. PubMed ID: 14996721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
    Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
    Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma.
    Kojima T; Shimazui T; Horie R; Hinotsu S; Oikawa T; Kawai K; Suzuki H; Meno K; Akaza H; Uchida K
    Genes Chromosomes Cancer; 2010 Apr; 49(4):379-89. PubMed ID: 20095040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer].
    Dahl E; Veeck J; An H; Wiesmann F; Klopocki E; Sauter G; Kristiansen G; Hartmann A; Knüchel R
    Verh Dtsch Ges Pathol; 2005; 89():169-77. PubMed ID: 18035687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.